Palmaz-Schatz stent determines the success or failure of newcomers
This article was originally published in Clinica
Executive Summary
Demonstrating equivalence is the name of the game for manufacturers seeking entry into the lucrative US stent market. In order to gain FDA approval these companies need to show that they are at least as good as the Palmaz-Schatz stent.